Pfizer and BioNTech to supply additional Covid-19 vaccine doses to US
Under the terms of the deal, the companies will supply 105 million doses of their Omicron-adapted Covid-19 vaccines,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jun 22
Under the terms of the deal, the companies will supply 105 million doses of their Omicron-adapted Covid-19 vaccines,…
29 Jun 22
The European regulator approved Nexviadyme to treat the full spectrum of Pompe disease and Xenpozyme to treat non-Central…
29 Jun 22
Imvanex is a non-replicating smallpox vaccine that contains a live modified form of the vaccinia virus, dubbed vaccinia…
28 Jun 22
The partnership leverages the cancer-fighting potential of iADCs as a novel modality, enabled by Sutro’s ability to engineer…
28 Jun 22
The expanded approval is based on data from the JUNIPERA trial, which showed that Cosentyx reduced the risk…
27 Jun 22
The FDA approval was based on data from the Phase 3 TRANSFORM trial and Phase 2 PILOT study,…
27 Jun 22
The investment will be implemented in two stages where the first stage will focus on developing vaccines, plasma,…
24 Jun 22
The expansion, which doubles the production of the highly potent active pharmaceutical ingredients (HPAPIs), builds on Merck’s 30…
24 Jun 22
The vaccine has also been recommended by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human…
23 Jun 22
The drug combination was indicated for metastatic solid tumours with BRAF V600E mutations in adults and children aged…